echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Professor Dieter A. Wolf's team discovered a new anti-tumor mechanism of mitochondrial inhibitors

    Professor Dieter A. Wolf's team discovered a new anti-tumor mechanism of mitochondrial inhibitors

    • Last Update: 2021-12-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    <>



    Recently, Xiamen University College of Pharmacy Dieter A.


    Abnormal energy metabolism is one of the most basic characteristics of cancer cells


    Professor Wolf ’s research group first discovered in 2013 that the small molecule compound SMIP004-7 can be used as an effective mitochondrial respiratory inhibitor.


    Hu Cheng, a doctoral student from the School of Pharmacy of Xiamen University, is the co-first author of the paper, Professor Dieter A.



    Paper link:

    https:// href="https://pubmed.


    (Photo / Text: School of Pharmacy, Xiamen University )


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.